This Came True

Two weeks ago, we flagged biotech drift — mid-cap firms under pressure to cut R&D budgets and pivot strategies.
Today, Arsenal Bio confirms the signal: 50% workforce reduction, reallocating capital to clinical advancement.

This is proof-based foresight in action.
The future is not noise — it is patterned, and the patterns are visible.

Codex: DCX-0017.09.19
#Biotech #Foresight #GISMethodStandard

Comments

Popular posts from this blog

🌐 GIS Foresight Report — September 2025 Edition

🌐 GIS Biotech Foresight Report — September 2025

🌍 GIS Intelligence Report — CΓ΄te d’Ivoire Presidential Election 2025